Default company panoramic image

ImmunID Technologies

Provider of solutions for the characterization and analysis of the immune system repertoire and the tracking of immune malfunctions

  • Stage $500K in TTM Revenue
  • Industry Biotechnology
  • Location France
  • Currency EUR
  • Founded April 2005
  • Employees 20
  • Website

Company Summary

ImmunID is specialized in Molecular Diagnostics solutions dedicated to the immune system. The company’s strategy is focused on improving prognostic and therapeutic decisions through the immune repertoire analysis. ImmunID has a dual business model and targets two distinct markets: 1) Development of a proprietary biomarkers platform dedicated to medical applications in Oncology 2) Immune testing services for the Pharma/Biotech industry


  • Default avatar
    Nicolas Pasqual
    CEO & CSO

    Nicolas Pasqual PhD, co-founder of ImmunID, is a pioneer in the analysis of immune status as biomarker of treatment efficiency. He has over 10 years experience in management of diagnostic development at ImmunID and CEA. Nicolas holds a PhD in immunology, cellular & molecular biology and graduated from the entrepreneurship program of the Lyon management school. He is Board member of the Lyonbiopole Competitive cluster and of Accinov.

  • Default avatar
    Sebastien Weisbuch

    Sebastien Weisbuch PhD, co-founder of ImmunID SAS, has over 9 years of extensive experience in operation management, beside the COO position, Sebastien Weisbuch is in charge of HR administration, Intellectual Property, Quality Assurance and CE product Management. Sebastien holds a PhD in Structural Biology and Nanobiology at the Grenoble University and graduated from EM Lyon.

  • Default avatar
    Nadia Plantier
    Business Devlopment

    Nadia has over 20 years of experience in Sales & Marketing of Diagnostic Product in Europe, US, Middle East and Africa and served as President of French and European Association of Veterinary Reagents Manufacturer. She has led international distribution of veterinary diagnostic products at Synbiotics Europe, covering more than 70 countries.

  • Default avatar
    Jean-François Mouret

    Jean-François PhD, PharmD, has over 20 years of experience in technical development, business development and team management. He was head of Business Development at Genostar and, as a co-founder, held the CTO position at Genome Express. He is Pharmacian responsible for products R&D programs, and Services. He is expert in molecular biology & sequencing as well as responsible for the production and industrialization of the Company’s tests.